Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Langenbucher

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cell Reports|June 15, 2022
YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4Nana Chen, Gabriel Golczer, Subhoshree Ghose, et al.
Cancer Research|May 2, 2024
Correction: Antibody-Peptide Epitope Conjugates for Personalized Cancer TherapySongfa Zhang, Chuan Yan, David G Millar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast CancerSiang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Cancer Research|December 30, 2021
Antibody-Peptide Epitope Conjugates for Personalized Cancer TherapySongfa Zhang, Chuan Yan, David G Millar, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell LymphomaYe Zhang, Lydie Debaize, Adam Langenbucher, et al.
Science Advances|December 5, 2025
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphomaYe Zhang, Lydie Debaize, Adam Langenbucher, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung CancerIbiayi Dagogo-Jack, Satoshi Yoda, Jochen K Lennerz, et al.
Molecular Cell|October 8, 2021
NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancerHongshan Guo, Gabriel Golczer, Ben S Wittner, et al.
Genome Biology|February 11, 2020
A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cellsSooncheol Lee, Douglas Micalizzi, Samuel S Truesdell, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cell Reports|June 15, 2022
YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4Nana Chen, Gabriel Golczer, Subhoshree Ghose, et al.
Cancer Research|May 2, 2024
Correction: Antibody-Peptide Epitope Conjugates for Personalized Cancer TherapySongfa Zhang, Chuan Yan, David G Millar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast CancerSiang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Cancer Research|December 30, 2021
Antibody-Peptide Epitope Conjugates for Personalized Cancer TherapySongfa Zhang, Chuan Yan, David G Millar, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell LymphomaYe Zhang, Lydie Debaize, Adam Langenbucher, et al.
Science Advances|December 5, 2025
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphomaYe Zhang, Lydie Debaize, Adam Langenbucher, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung CancerIbiayi Dagogo-Jack, Satoshi Yoda, Jochen K Lennerz, et al.
Molecular Cell|October 8, 2021
NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancerHongshan Guo, Gabriel Golczer, Ben S Wittner, et al.
Genome Biology|February 11, 2020
A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cellsSooncheol Lee, Douglas Micalizzi, Samuel S Truesdell, et al.
Pageof 3